Publicly listed company Applied DNA Sciences discloses that its initial BNB holdings are valued at over $17 million.

ChainCatcher reported that biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced the completion of its previously disclosed private investment in public equity (PIPE) financing, led by institutional DeFi and TradFi investors, with its initial BNB holdings valued at over $17 million.

The PIPE brought the company approximately $27 million in total proceeds, with the potential to receive up to an additional $31 million in total proceeds through the exercise of warrants in the future. The total proceeds from the PIPE transaction include $15.3 million in cash and stablecoins, as well as OBNB trust units valued at $11.71 million. The company received a total of 435,638 trust units, which represent underlying ownership of 10,647 BNB tokens. The company also announced today that it has additionally purchased 4,908 BNB tokens, with an estimated total value of $5.3 million as of 10:00 PM (UTC+8), October 20, 2025, Eastern Time.